Feedback / Questions
MTX325 - Mission Therap
https://www.prnewswire.com/news-releases/mission-therapeutics-raises-13-3-million-to-progress-first-in-class-parkinsons-disease-candidate-mtx325-through-clinical-trials-302583772.html
Oct 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next